Edoardo Giacopuzzi retweeted
In Brief: The @uk_biobank adds a detailed immune dataset to its repository to enable a better understanding of how immune variation affects health, aging and disease nature.com/articles/s41587-0…
rdcu.be/dV9WEME5S6Ya
Edoardo Giacopuzzi retweeted
1/ I’m thrilled to share a new preprint, where we investigate how long-range sequence-to-function (S2F) models like Enformer, Borzoi and AlphaGenome learn variant effects during post-training: biorxiv.org/content/10.64898…
Edoardo Giacopuzzi retweeted
Introducing Manimble: a free, open-source slide editor in which every slide is a Manim program (so underlying the deck is Python). It alows for editing like in Keynote or PowerPoint while seamlessly incorporating AI edits / animations. pachterlab.github.io/Manimbl…
1/🧵
Edoardo Giacopuzzi retweeted
Really happy to share our new paper, now out in Nature Communications and open access.
We all know most GWAS hits sit in noncoding DNA, and one way they act is by changing how genes are spliced. But splicing is exquisitely cell-type-specific, and bulk RNA-seq averages all of that away. So we went to single cells.
Using the OneK1K cohort, 980 people with matched genotypes and single-cell RNA-seq of their blood immune cells, we mapped splicing regulation across 13 immune cell types: 3,337 independent cis-splicing QTLs, with subsets that differ by sex and by age. When we overlaid these on GWAS, the splicing signals colocalized with risk loci for 30 complex traits, and autoimmune disease, type 1 diabetes in particular, stood out.
My favourite part is a trans story: variants that act from a distance on RPS24 splicing, through the splicing cofactor IVNS1ABP and its interaction with HNRNPK. A small mechanistic chain, from variant to regulator to splicing, exactly the kind of thing single-cell data lets you see.
Together with our 2024 Nature Genetics paper, which did the same in Asian populations, they give a fuller picture of how splicing variation shapes disease risk across ancestries, and a lot of that picture is still cell-type-specific.
Congratulations to first authors Yan Liang and Yi Xia, and to Chi Tian, Yuntian Zhang, Yuhao Dong, and strong support from @drjosephpowell and Alex Hewitt.
Paper: nature.com/articles/s41467-0…
Edoardo Giacopuzzi retweeted
Behold: The full JUMP Cell Painting chemical dataset preprint!
Images + 1.53 billion single-cell profiles for 115,796 compounds in human cells, made across 12 labs. All freely available 🧵 biorxiv.org/content/10.1101/…
Edoardo Giacopuzzi retweeted
Estimating the completeness of large-scale single-cell sequencing projects
nature.com/articles/s41467-0…
Edoardo Giacopuzzi retweeted
Our jaxQTL paper is out today in Nature Genetics! 🧬
We developed highly efficient count-based models that improves single-cell eQTL discovery and reveal cell-type-specific genetic regulation.
nature.com/articles/s41588-0…
Edoardo Giacopuzzi retweeted
UMAP 0.6 is out! A new initialization, new optimizers and faster nearest neighbour search make UMAP much faster and far better at large scale. On 3 million arXiv papers it finishes in under 5 minutes, before UMAP 0.5 has even found its nearest neighbours.
Edoardo Giacopuzzi retweeted
Single-cell atlases continue to map the diversity of cell states, but how can we use them to interpret non-coding genetic variants?
Excited to share AlphaGenome 2, our model for predicting cell-type-specific regulatory activity and variant effects from DNA sequence.
deepmind.google/blog/alphage…
How might we identify genes, cell types and molecular mechanisms of a complex trait/disease, when single cell gene expression data may never be available in the same cohorts we perform GWAS on, especially in cell types that are hard to access? 1/n
Edoardo Giacopuzzi retweeted
Excited to share Seurat v6 and scSLIDE!
Single-cell studies usually compare cells, but scSLIDE lets us compare *samples*. Instead of forcing patients into case/control groups, we can model sample-level variation.
Paper: cell.com/cell/abstract/S0092…
Software: satijalab.org/seurat
Why do genetically identical cells of the same type behave so differently? Can DNA shape how variable that behaviour is?
Our paper is out in @NatureComms. We built MEOTIVE to find genetic variants associated with cell-to-cell variability in expression. 🧵
nature.com/articles/s41467-0…
Edoardo Giacopuzzi retweeted
SAIGE-QTL is out in @NatureGenet! nature.com/articles/s41588-0…
SAIGE-QTL is a robust and efficient method for single-cell eQTL mapping, which 👇 (1/n)
Edoardo Giacopuzzi retweeted
1/ 🔥New study: Most perturbation models answer “if I knock out gene X, what happens?” We asked inverse: given a disease state, what drove them? 🔄
ExPert traces patient cells to their cause: hidden liver-disease biology, mitochondrial defects from blood biorxiv.org/content/10.64898…
Edoardo Giacopuzzi retweeted
In the latest issue! Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits dlvr.it/TW7dk3
Edoardo Giacopuzzi retweeted
Scooby-2: fine-tuning AlphaGenome for single-cell genomic track prediction biorxiv.org/content/10.64898…
Edoardo Giacopuzzi retweeted
Given substantial size relative to other widely available imputation panels, the 490k-based UK Biobank imputation panel demonstrates improved imputation across diverse ancestries nature.com/articles/s41588-0… @NatureGenet
Edoardo Giacopuzzi retweeted
CellWhisperer uses multimodal learning of transcriptomes and text to answer questions about single-cell RNA-sequencing data go.nature.com/3WPGJnW
rdcu.be/TamrmUPBYm6a
Our three TenK10K papers are out in @Nature today!
I am honoured to lead one of the studies addressing the "missing regulation" puzzle for human complex diseases, integrating gene expression and chromatin accessibility of 9M PBMCs from 1925 donors.
nature.com/articles/s41586-0…
Edoardo Giacopuzzi retweeted
Can someone find your genome using your electronic health record? 🔍 🧬
A new study in @NatureComms explores genome re-identification using polygenic scores.
Imagine someone has your medical records with your height, weight, BMI and blood test results. They also have a database of hundreds of thousands of anonymous genomes. Can they find yours?
The idea is simple. Calculate polygenic scores for each genome and compare predicted traits with real ones. The authors developed PGMatch, an algorithm that accounts for prediction accuracy and correlations between traits.
They tested it on UK Biobank data using 40 traits.
With equal numbers of matching and non-matching pairs, the algorithm achieved over 99% precision at 40% recall.
But with just one real match per 1,000 incorrect pairs, average precision dropped to 13.4%.
Interestingly, earlier research showed that GWAS participation could be detected with 98% sensitivity at a false positive rate of 0.1% using 50,000 SNPs in a study of 2,000 people. However, this required knowing the person's genotype.
The conclusion is that even with access to your medical records and a huge database of anonymous genomes, finding yours would be extremely difficult.
So for now, no one is likely to identify your genome and use it to poison you with whole milk after discovering that you are lactose intolerant.
nature.com/articles/s41467-0…
#PRS #GWAS #anonymization #UKBiobank
























